Abstract
A randomized clinical trial involving youths ages 6 to 18 who received an antipsychotic for symptoms of aggression has found that antipsychotic exposure was associated with adverse changes in body fat and insulin sensitivity. These findings raise concern because these factors are known contributors to early‐onset type 2 diabetes and cardiovascular disease.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
